Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines

Biologicals

Volumn 40, Issue 1, 2012, Pages 36-40

  Jensen, Sten E ^a   Engelhart Illigen, Kristin E ^a   Badsberg, Jens Henrik ^a   Hasløv, Kaare R ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Acellular pertussis vaccine; HIST test; Histamine sensitization test; Pertussis toxin

Indexed keywords

ALUMINUM; HISTAMINE; PERTUSSIS TOXIN; PERTUSSIS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CONTAMINATION; DRUG QUALITY; ENDOTOXIN DETECTION; FEMALE; HISTAMINE SENSITIZATION TEST; IMMUNE FUNCTION TEST; LIMIT OF DETECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SKIN TEMPERATURE; TEMPERATURE MEASUREMENT; VALIDATION PROCESS;

ANIMALS; BIOLOGICAL ASSAY; DRUG CONTAMINATION; HISTAMINE; HISTAMINE AGONISTS; HUMANS; MICE; PERTUSSIS TOXIN; PERTUSSIS VACCINE; SENSITIVITY AND SPECIFICITY; SKIN TEMPERATURE;

MUS;

EID: 84856459012     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.09.015     Document Type: Article

References (17)

1. Pertussis vaccines WHO position paper. Wkly Epidemiol Rec 2010, 85:385-400.
2. European Pharmacopoeia Suppl. 6.0, monograph 01/2008: 1356: pertussis vaccine (acellular, component, adsorbed) 2008, Council of Europe, Strasbourg.
3. Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines, World Health Organ Tech Rep Ser no. 878 1998, 57-76.
4. Xing D., Maes A., Behr-Gross M.-E., Costanzo A., Daas A., Buchheit K.-H. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines. Pharmeur Bio Sci Notes 2010, 2010(1):51-63.
5. Knezevic I., Baca-Estrada M., Xing D.K., Lei D. WHO working group meeting on standardization of acellular pertussis vaccines: potency assay. Vaccine 2008, 26:3960-3968.
6. Russell W.M.S., Burch R.L. The principles of humane experimental technique 1959, Methuen & Company Ltd., London.
7. Ishida S., Kurokawa M., Asakawa S., Iwasa S. Asensitive assay method for the histamine-sensitizing factor using change in rectal temperature of mice after histamine challenge as response. JBiol Stand 1979, 7:21-29.
8. Ochiai M., Yamamoto A., Kataoka M., Toyoizumi H., Arakawa Y., Horiuchi Y. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine. Biologicals 2007, 35:259-264.
9. Gaines-Das R., Ochiai M., Douglas-Bardsley A., Asokanathan C., Horiuchi Y., Rigsby P., et al. Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines. Hum Vaccin 2009, 5:166-171.
10. Jensen S.E., Engelhart Illigen K.E., Hasløv K.R. Letter to the editor: an alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines. Pharmeur Bio Sci Notes 2010, 2010(1):73-74.
11. Dobbelaer R., Daas A., Esposito-Farese M.-E. Collaborative study for the establishment of a European pharmacopoeia biological reference preparation for pertussis toxin - part 1. Pharmeuropa Spec Issue Bio 2001, 2001(1):15-23.
12. ICH harmonised tripartite guideline Validation of analytical procedures: text and methodology Q2(R1). Proceedings of the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use 2005, Geneva, Switzerland.
13. Gaines-Das R., North D. Implications of experimental technique for analysis and interpretation of data from animal experiments: outliers and increased variability resulting from failure of intraperitoneal injection procedures. Lab Anim 2007, 41:312-320.
14. Xing D., Gaines-Das R., Newland P., Corbel M. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration. Vaccine 2002, 20:3535-3542.
15. Hoonakker M.E., Ruiterkamp N., Hendriksen C.F. The cAMP assay: a functional invitro alternative to the invivo histamine sensitization test. Vaccine 2010, 28:1347-1352.
16. Isbrucker R.A., Bliu A., Prior F. Modified binding assay for improved sensitivity and specificity in the detection of residual pertussis toxin in vaccine preparations. Vaccine 2010, 28:2687-2692.
17. Yuen C.-T., Horiuchi Y., Asokanathan C., Cook S., Douglas-Bardsley A., Ochiai M., et al. An invitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccines. Vaccine 2010, 28:3714-3721.